[1]CHAMOLI A,GOSAVI AS,SHIRWADKAR UP,et al.Overview of oral cavity squamous cell carcinoma:Risk factors,mechanisms,and diagnostics [J].Oral Oncol,2021,121:105451.
[2]MELO BAC,VILAR LG,OLIVEIRA NR,et al.Human papillomavirus infection and oral squamous cell carcinoma-a systematic review [J].Braz J Otorhinolaryngol,2021,87(3):346-352.
[3]BRAY F,FERLAY J,SOERJOMATARAM I,et al.Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J].CA Cancer J Clin,2018,68(6):394-424.
[4]KUMARI P,KUMAR S,SETHY M,et al.Identification of therapeutically potential targets and their ligands for the treatment of OSCC[J].Front Oncol,2022,12:910494.
[5]MALOVAN G,HIERZBERGER B,SURACI S,et al.The emerging role of dipeptidyl peptidase 3 in pathophysiology[J].FEBS J,2023,290(9):2246-2262.
[6]YE P,DUAN W,LENG YQ,et al.DPP3:From biomarker to therapeutic target of cardiovascular diseases [J].Front Cardiovasc Med,2022,9:974035.
[7]PRAJAPATI SC,CHAUHAN SS.Dipeptidyl peptidase III:a multifaceted oligopeptide N-end cutter [J].FEBS J,2011,278(18):3256-3276.
[8]LIU JK,ABUDULA A,YANG HT,et al.DPP3 expression promotes cell proliferation and migration in vitro and tumour growth in vivo,which is associated with poor prognosis of oesophageal carcinoma [J].Oncol Rep,2023,49(1):9.
[9]TONG Y,HUANG Y,ZHANG Y,et al.DPP3/CDK1 contributes to the progression of colorectal cancer through regulating cell proliferation,cell apoptosis,and cell migration [J].Cell Death Dis,2021,12(6):529.
[10]LU K,ALCIVAR AL,MA J,et al.NRF2 induction supporting breast cancer cell survival is enabled by oxidative stress-induced DPP3-KEAP1 interaction [J].Cancer Res,2017,77(11):2881-2892.
[11]HAST BE,GOLDFARB D,MULVANEY KM,et al.Proteomic analysis of ubiquitin ligase KEAP1 reveals associated proteins that inhibit NRF2 ubiquitination [J].Cancer Res,2013,73(7):2199-2210.
[12]SINGH R,SHARMA MC,SARKAR C,et al.Transcription factor C/EBP-β mediates downregulation of dipeptidyl-peptidase III expression by interleukin-6 in human glioblastoma cells [J].FEBS J,2014,281(6):1629-1641.
[13]MATIC A,SUPLJIKA F,BRKIC H,et al.Identification of an additional metal-binding site in human dipeptidyl peptidase III [J].Int J Mol Sci,2023,24(16):12747.
[14]SATO A,OGITA H.Pathophysiological implications of dipeptidyl peptidases [J].Curr Protein Pept Sci,2017,18(8):843-849.
[15]SILVA-ISLAS CA,MALDONADO PD.Canonical and non-canonical mechanisms of Nrf2 activation [J].Pharmacol Res,2018,134:92-99.
[16]TANIGUCHI K,KARIN M.NF-κB,inflammation,immunity and cancer:coming of age [J].Nat Rev Immunol,2018,18(5):309-324.
[17]HOU CX,MAO GY,SUN QW,et al.Metabolomic analysis reveals that SPHK1 promotes oral squamous cell carcinoma progression through NF-κB activation [J].Ann Surg Oncol,2022,29(12):7386-7399.
[18]李丽,陈玉婷,曾希.RelA/p65的磷酸化调节及其与肿瘤的关系[J].中南医学科学杂志,2018,46(02):216-220.
LI L,CHEN YT,ZENG X.Phosphorylation regulation of RelA/p65 and its relationship with tumors [J].JCSUMS,2018,46(02):216-220.
[19]GUTIERREZ H,DAVIES AM.Regulation of neural process growth,elaboration and structural plasticity by NF-κB [J].Trends Neurosci,2011,34(6):316-325.